MedPath

Comparison of intraoperative administration of ketorolac with morphine in pain control and postoperative nausea and vomiting in patients undergoing rhinoplasty

Phase 2
Recruiting
Conditions
Rhinoplasty surgery.
General- and plastic-surgery devices associated with adverse incidents
Registration Number
IRCT20210415050976N8
Lead Sponsor
Jahrom University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
114
Inclusion Criteria

Rhinoplasty under general anesthesia
No history of allergy to morphine and ketorolac

Exclusion Criteria

Drug addiction
Underlying cardiovascular disease
Patients with coagulation disorders or platelets less than one hundred thousand
Patients with a history of renal insufficiency and serum creatinine more than one and a half

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The pain. Timepoint: Periods immediately after surgery, 15 minutes, 3 hours and 6 hours after surgery. Method of measurement: VAS criteria.;Nausea and vomiting. Timepoint: After surgery. Method of measurement: Nausea and vomiting questionnaire.
Secondary Outcome Measures
NameTimeMethod
Vital signs. Timepoint: Immediately after surgery and then at 15, 3 and 6 minutes after surgery. Method of measurement: monitoring.
© Copyright 2025. All Rights Reserved by MedPath